SEC Tracker
Get the app

Cogent Biosciences COGT

Cogent Biosciences Q3 FY26: net loss $111.4M; diluted EPS −$0.59

Form
10-Q
Filed
Period
Importance
Notable

The plain-English summary is being written. The app sends it the moment it is ready.

Open in the appGet the appView on EDGAR

Get an email when Cogent Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. uniQure QURE public float $765M, Jun 30, 2025
  2. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  3. Pacira BioSciences PCRX public float $758M, Jun 30, 2025
  4. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  5. Nurix Therapeutics NRIX public float $808M, May 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.